RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Machine Learning Model in Obesity to Predict Weight Loss One Year after Bariatric Surgery: A Pilot Study
[EN] Roux-en-Y gastric bypass (RYGB) is a treatment for severe obesity. However, many patients have insufficient total weight loss (TWL) after RYGB. Although multiple factors have been involved, their influence is incompletely known. The aim of this exploratory study was to evaluate the feasibility and reliability of the use of machine learning (ML) techniques to estimate the success in weight loss after RYGP, based on clinical, anthropometric and biochemical data, in order to identify morbidly obese patients with poor weight responses. We retrospectively analyzed 118 patients, who underwent RYGB at the Hospital Clínico Universitario of Valencia (Spain) between 2013 and 2017. We applied a ML approach using local linear embedding (LLE) as a tool for the evaluation and classification of the main parameters in conjunction with evolutionary algorithms for the optimization and adjustment of the parameter model. The variables associated with one-year postoperative %TWL were obstructive sleep apnea, osteoarthritis, insulin treatment, preoperative weight, insulin resistance index, apolipoprotein A, uric acid, complement component 3, and vitamin B12. The model correctly classified 71.4% of subjects with TWL < 30% although 36.4% with TWL ¿ 30% were incorrectly classified as ¿unsuccessful procedures¿. The ML-model processed moderate discriminatory precision in the validation set. Thus, in severe obesity, ML-models can be useful to assist in the selection of patients before bariatric surgery., This research was funded by Instituto de Salud Carlos III, grant numbers PI15/00082, PIE15/00013, PI21/00220, and Conselleria de Educacion, Cultura y Deporte, Generalitat Valenciana, grant number AICO 2019/250 to L.P. and Prometeo/2021/046 to J.J.R. This work was also supported by Ministerio de Economia, Industria y Competitividad, grant number SAF2014-57845-R and by Ministerio de Ciencia e Innovacion, Agencia Estatal de Investigacion (MCIN/AEI/10.13039/501100011033) and Fondo Europeo de Desarrollo Regional (FEDER) (Project PID2022-141512NB-I00) to J.J.R. The authors also received financial support from CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), a research network of the Ministry of Health, Madrid, to J.T.R.
Proyecto:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-141512NB-I00
,
Instituto de Salud Carlos III / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) PI21/00220
,
Ministerio de Economía y Competitividad PI15/00082
,
Ministerio de Economía y Competitividad PIE15/00013
,
Ministerio de Economía y Competitividad SAF2014-57845-R
,
Generalitat Valenciana PROMETEO/2021/046
,
Generalitat Valenciana AICO/2019/250